Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
Clinical trial NCT07662928 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662928
- Sponsor
- AIDS Malignancy Consortium
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-17
- Primary completion
- 2031-05-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.